...
首页> 外文期刊>Oncology letters >miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin
【24h】

miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin

机译:miRNA-335和miRNA-182通过靶向survivin影响舌鳞状细胞癌的发生

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the present study was to characterize the roles of two microRNAs (miRs) that have been reported to be differentially expressed in tongue squamous cell carcinoma (TSCC), miR-335 and miR-182. In total, 20 tumor tissue samples and 20 corresponding adjacent non-cancerous samples were collected from patients with TSCC to measure the expression of miR-335 and miR-182 and the potential shared target of these miRs, survivin, using reverse transcription-quantitative polymerase chain reaction and western blotting. In the TSCC tissue samples, significantly decreased expression of the two miRs and increased expression of survivin were detected compared with adjacent non-cancerous controls. Subsequently, it was confirmed that survivin was the target gene of miR-335 and miR-182 using a luciferase assay in TSCC cells. In order to examine the function of miR-335 and miR-182 in the development of TSCC, TSCC cells were transiently transfected with the mimics of the two miRs, and it was confirmed that the introduction of miR-335 and miR-182 to cells suppressed the expression of survivin and markedly inhibited the proliferation of the TSCC cells. Furthermore, miR-335 and miR-182 were found to induce cell cycle arrest by suppressing the expression of survivin. The present study revealed a negative regulatory role of miR-335 and miR-182 in the proliferation of TSCC cells by targeting survivin, and miR-335 and miR-182 may be novel therapeutic targets for the treatment of TSCC.
机译:本研究的目的是表征两个已报道在舌鳞状细胞癌(TSCC),miR-335和miR-182中差异表达的微小RNA(miR)的作用。总共从TSCC患者中收集了20个肿瘤组织样本和20个相应的相邻非癌性样本,使用逆转录定量聚合酶来测量miR-335和miR-182的表达以及这些miRs survivin的潜在共有靶标。链反应和蛋白质印迹。在TSCC组织样品中,与相邻的非癌性对照相比,检测到两个miR的表达显着降低,而survivin的表达则升高。随后,通过萤光素酶测定法在TSCC细胞中证实了存活蛋白是miR-335和miR-182的靶基因。为了检查miR-335和miR-182在TSCC发育中的功能,用两个miRs的模拟物瞬时转染了TSCC细胞,并证实将miR-335和miR-182引入细胞抑制survivin的表达并明显抑制TSCC细胞的增殖。此外,发现miR-335和miR-182通过抑制survivin的表达诱导细胞周期停滞。本研究通过靶向survivin揭示了miR-335和miR-182在TSCC细胞增殖中的负调控作用,而miR-335和miR-182可能是治疗TSCC的新型治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号